title: Resident rounds Part III: Metastatic melanoma patient on vemurafenib develops multiple primary cutaneous melanomas.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Brackeen
authors.forename: Jordan
authors.initials: J
authors.lastname: Jamerson
authors.forename: Amy
authors.initials: A
authors.lastname: Brackeen
mesh_terms: D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008545:Melanoma / Q000175:diagnosis* / Q000188:drug therapy*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012878:Skin Neoplasms; D013449:Sulfonamides / Q000627:therapeutic use*; D000077484:Vemurafenib; D000096142:Cutaneous Malignant Melanoma
chemical_list: D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib